Shock (Septic, Cardiogenic, Hypovolemic, Obstructive, Anaphylactic) — Clinical Documentation Guide (2026)

This Clinical Documentation Guide (CDG) provides AAPC/AHIMA-credentialed coders and CDI specialists with comprehensive coding, clinical, and documentation guidance for shock in all its major subtypes — septic, cardiogenic, hypovolemic, obstructive, and anaphylactic. Content reflects FY2026 ICD-10-CM Official Guidelines (effective October 1, 2025), incorporating sequencing mandates for septic shock under Guideline I.C.1.d.5, HCC v28 RAF weights, MS-DRG impact analysis, CPT 2026 procedure codes, and AHIMA/ACDIS-compliant CDI query templates. Shock codes carry MCC status across virtually all subtypes — accurate documentation and sequencing directly drive reimbursement, risk adjustment, and audit defense.

🔍 1. Definition

Shock is a life-threatening, time-sensitive syndrome of acute circulatory failure resulting in inadequate oxygen delivery to meet cellular metabolic demands, leading to cellular dysfunction, organ injury, and death if untreated. The clinical hallmark is end-organ hypoperfusion — not merely hypotension. Per the NCBI Shock Reference, the cardinal features are: (1) hemodynamic instability, (2) evidence of tissue hypoperfusion, and (3) cellular metabolic dysfunction.

Critical documentation principle: Isolated hypotension (e.g., SBP < 90 mmHg) without documented end-organ hypoperfusion — such as elevated lactate, acute kidney injury, altered mental status, oliguria, or abnormal liver function — does not automatically meet clinical criteria for shock. Documentation must reflect both the hemodynamic instability and the evidence of impaired perfusion to support the diagnosis.

The five principal shock subtypes recognized in ICD-10-CM FY2026 are:

• Septic shock (R65.21): Shock due to systemic infection with persistent hypotension requiring vasopressors and lactate >2 mmol/L despite adequate fluid resuscitation — per Sepsis-3 definition (Singer et al., JAMA 2016).
• Cardiogenic shock (R57.0): Pump failure with SBP <90 mmHg for >30 minutes, cardiac index (CI) <2.2 L/min/m², pulmonary capillary wedge pressure (PCWP) >15 mmHg, and evidence of hypoperfusion.
• Hypovolemic shock (R57.1): Reduced intravascular volume from hemorrhage, dehydration, or third-spacing, causing inadequate preload and reduced cardiac output.
• Obstructive shock: Mechanical obstruction to blood flow — classically pulmonary embolism (I26.x), cardiac tamponade (I31.4), or tension pneumothorax. Coded via the underlying cause in ICD-10-CM.
• Anaphylactic shock (T78.2xxA, T80.5xxA, T88.6xxA, T78.0x-T78.09): Severe, systemic allergic response causing distributive shock via massive histamine release and vasodilation.

🗂️ 2. Alternative Terminology

Clinical staff use varied terminology in documentation. The following table lists formal, colloquial, and lay terms that coders and CDI specialists must recognize to support appropriate code assignment and query triggers.

🩺 3. Signs & Symptoms

Clinical documentation must reflect specific signs, symptoms, and objective markers supporting each shock subtype. CDI specialists should flag encounters where shock is clinically evident but not explicitly named or typed by the provider.

Universal Shock Indicators (all subtypes)

• Hypotension: SBP <90 mmHg or MAP <65 mmHg — necessary but not sufficient alone
• Tachycardia: HR >100 bpm (compensatory); may be absent in neurogenic shock (bradycardia)
• Altered mental status: Confusion, agitation, obtundation, coma — cerebral hypoperfusion
• Oliguria / anuria: UO <0.5 mL/kg/hr — renal hypoperfusion; supports AKI coding (N17.x)
• Elevated lactate: >2 mmol/L (tissue hypoperfusion marker); >4 mmol/L = refractory/severe
• Cool, clammy, mottled skin: Peripheral vasoconstriction (hypovolemic, cardiogenic); warm/flushed in early distributive shock
• Capillary refill >2 seconds
• Metabolic acidosis: Lactic acidosis, elevated anion gap

Subtype-Specific Clinical Markers

🧭 4. Differential Diagnosis

Accurate shock subtype identification is critical for sequencing, DRG assignment, and HCC capture. The following differentials must be considered and — when co-existing conditions are confirmed — may require additional codes.

📋 5. Clinical Indicators for Coders/CDI

The following clinical indicators, when present in the medical record, should prompt documentation review and/or CDI query to ensure complete and accurate shock code assignment.

🦴 6. Anatomy & Pathophysiology

Understanding shock pathophysiology enables CDI specialists to recognize when hemodynamic deterioration reflects a specific shock subtype requiring documentation and when comorbid organ dysfunction codes must be captured.

Shared Pathophysiological Pathway

Regardless of subtype, all shock states converge on the same final common pathway: decreased oxygen delivery (DO2) relative to oxygen consumption (VO2) → anaerobic metabolism → lactate accumulation → cellular energy failure → organ dysfunction → death. Per UpToDate: Shock Definition and Classification, DO2 = CO × CaO2, where cardiac output (CO) = HR × SV, making any reduction in HR, SV, or arterial oxygen content a potential trigger.

Subtype-Specific Pathophysiology

• Septic shock: Pathogen-associated molecular patterns (PAMPs) activate innate immunity → cytokine storm (TNF-α, IL-1, IL-6) → endothelial dysfunction → vasoplegia (profound ↓SVR) → distributive hypoperfusion. Myocardial depression (sepsis cardiomyopathy) further reduces CO. Microvascular thrombosis and capillary leak compound organ injury. Per Sepsis-3 criteria (JAMA 2016).
• Cardiogenic shock: Acute loss of left ventricular contractility (most commonly from AMI — per AHA/ACC 2022 Cardiogenic Shock Guidelines) → ↓SV → compensatory ↑SVR → further ↑afterload → vicious cycle of worsening pump failure. Pulmonary edema results from ↑LVEDP and ↑PCWP.
• Hypovolemic shock: ↓Preload from blood/fluid loss → ↓SV → ↑HR, ↑SVR (compensatory) → insufficient to maintain CO → end-organ ischemia. Four hemorrhagic shock classes (I–IV) based on estimated blood loss per ATLS 10th Edition: Class III (>30% EBL) and IV (>40% EBL) carry life-threatening hemodynamic compromise.
• Obstructive shock: Mechanical impedance to RV outflow (PE) or ventricular filling (tamponade, tension pneumo) → ↓CO despite normal/↑cardiac filling pressures. Tamponade: pericardial fluid compresses cardiac chambers (pulsus paradoxus reflects inspiratory ↓LV filling). PE: acute RV dilation → interventricular septal shift → ↓LV preload.
• Anaphylactic shock: IgE-mediated mast cell/basophil degranulation → histamine, tryptase, leukotrienes, prostaglandins → ↓↓SVR + ↑vascular permeability + bronchospasm. The distributive pattern is similar to septic shock but onset is rapid (seconds to minutes). Per AAAAI/ACAAI Anaphylaxis Guidelines 2020.

Organ Dysfunction Coding Opportunities

Shock-induced organ dysfunction must be documented and coded separately when present. Each complication is typically an MCC or CC that significantly affects DRG assignment:

• Acute kidney injury (N17.0–N17.9) — most common; document stage (oliguric, anuric, requiring dialysis)
• Acute respiratory failure (J96.00–J96.01) — type 1 (hypoxic) vs. type 2 (hypercapnic)
• Acute hepatic failure (K72.00–K72.01) — “shock liver,” transaminitis >1000 IU/L
• DIC (D65) — septic, obstetric, and traumatic shock
• Encephalopathy (G93.40, G93.41) — septic encephalopathy when provider-documented
• Coagulopathy (D68.9 or specific) — distinguish from DIC

💊 7. Medication Impact / Treatment

Vasopressor and inotrope administration is the pharmacologic hallmark of hemodynamically significant shock. Documentation of which agents were used, for how long, and at what doses supports clinical validity for shock diagnosis and has direct impact on HCPCS coding (Part B/outpatient) and nursing acuity capture.

Vasopressors (First-Line)

• Norepinephrine (Levophed): First-line vasopressor for septic shock per Surviving Sepsis Campaign 2021. Acts on α1-adrenergic receptors → ↑SVR. HCPCS: typically J3490 (unlisted drug) or report by NDC.
• Vasopressin: Second-line agent to reduce norepinephrine requirements in septic shock; acts on V1 receptors. HCPCS: J3364 (not separately billable inpatient; J3490 outpatient).
• Epinephrine (J0171): Preferred for anaphylactic shock (IM auto-injector or IV infusion); also used in refractory septic/cardiogenic shock. HCPCS J0171 per 0.1 mg.
• Dopamine (J1265): No longer first-line for septic shock (higher arrhythmia risk per De Backer NEJM 2010); still used in certain cardiogenic shock scenarios. HCPCS J1265 per 40 mg.
• Dobutamine (J1250): Inotrope for cardiogenic shock; ↑CO without significant vasoconstriction. HCPCS J1250 per 250 mg.

Adjunctive Medications

• Hydrocortisone (J1720): For septic shock refractory to vasopressors — 200 mg/day IV per Surviving Sepsis Campaign 2021. HCPCS J1720 (up to 100 mg) or J1710 (up to 25 mg); inpatient covered under DRG — not separately billable Part B inpatient.
• Diphenhydramine + H2 blocker: Adjunctive for anaphylactic shock (not first-line; epinephrine remains first-line).
• Broad-spectrum antibiotics: Mandatory within 1 hour for septic shock per Surviving Sepsis Campaign; selection drives organism-specific coding (A41.x).
• IV crystalloids (0.9% NS or LR): 30 mL/kg initial bolus for septic shock; large-volume resuscitation for hypovolemic shock. Balanced crystalloids preferred per SMART Trial NEJM 2018.
• Naloxone (J2310): For opioid-related distributive shock/hemodynamic compromise. HCPCS J2310 per 1 mg.
• Morphine (J2270): Used in cardiogenic shock/acute pulmonary edema context (use with caution; CAUTION-HF data suggests potential harm). HCPCS J2270 per 10 mg.

Mechanical Circulatory Support

• Intra-aortic balloon pump (IABP): CPT 33967/33968 insertion/removal; augments coronary perfusion in cardiogenic shock
• Percutaneous VAD (Impella, TandemHeart): CPT 33990 (insertion, femoral) / 33991 (insertion, femoral, open) / 33992 (removal) / 33993 (repositioning)
• ECMO: CPT 33960–33966; used for refractory cardiogenic or septic shock with combined cardiac and respiratory failure

Preview ends here. The full guide continues with FY2026 ICD-10-CM code sets, CPT surgical coding, MS-DRG mapping, reimbursement guidance, CDI query templates, and an audit checklist — all available to CCO Members.

← Back to All Clinical Documentation Guides

📘 8. ICD-10-CM Guidelines (FY2026)

Shock is governed by multiple sections of the FY2026 ICD-10-CM Official Guidelines for Coding and Reporting. Sequencing errors in shock — particularly septic shock — are among the most common and financially consequential audit findings in inpatient coding.

Guideline I.C.1.d — Sepsis and Septic Shock Sequencing

• I.C.1.d.1: For a patient admitted for sepsis (A41.9 or specific A41.x), the sepsis code is PDx. When sepsis results from a localized infection (e.g., UTI, pneumonia), the sepsis code still goes first if sepsis is the reason for admission. The localized infection is coded as an additional diagnosis.
• I.C.1.d.2: A code from subcategory R65.2- (severe sepsis) is required any time sepsis is documented with organ dysfunction. R65.20 = without shock; R65.21 = with septic shock.
• I.C.1.d.5: Septic shock. If the reason for admission is septic shock, sequence: (1) systemic infection code, (2) R65.21, (3) any acute organ dysfunction codes. Per guideline: “Code R65.21, Severe sepsis with septic shock, can never be assigned as a principal diagnosis.”
• I.C.1.d.6: Severe sepsis may be present on admission or develop during the admission. If it develops post-admission, the underlying infection is still PDx; R65.20 or R65.21 is added as secondary.

Guideline I.C.19 — Injury, Traumatic Shock

Traumatic shock (T79.4xxA) is classified under Chapter 19 (Injury/Poisoning). Per Guideline I.C.19, the most severe injury is typically sequenced as PDx. T79.4xxA is reported as an additional code when traumatic shock complicates the injury. The 7th character “A” denotes initial encounter; “D” subsequent; “S” sequela.

Guideline I.C.15 — Obstetric Shock

Shock occurring during or following labor/delivery is coded to O75.1 (Shock during or following labor and delivery). Chapter 15 (Obstetric) codes take precedence over R57.x codes in obstetric patients. O75.1 is always an additional code — the obstetric complication/condition causing the shock is PDx.

Guideline I.C.19 — Postprocedural Shock (T81.1x)

Shock occurring in the postoperative period is coded to T81.1x when it represents a complication of the procedure itself. Key distinctions:

• T81.10xA: Postprocedural shock, unspecified — use only when subtype cannot be determined
• T81.11xA: Postprocedural cardiogenic shock
• T81.12xA: Postprocedural septic shock (+ infection code as PDx)
• T81.19xA: Other postprocedural shock (hypovolemic, anaphylactic)

Do NOT use T81.1x if the shock pre-dated the procedure or is clearly attributable to the underlying condition rather than the procedure itself. CDI query is appropriate when this distinction is unclear.

Guideline I.C.1 / I.C.19 — Anaphylactic Shock Cause Documentation

Anaphylactic shock codes require identification of the causative agent. The appropriate T-code (T78.0x for food, T80.5 for serum, T88.6 for drug adverse effect) is sequenced as the primary code for anaphylaxis, with 7th characters required: A (initial), D (subsequent), S (sequela). When cause is unknown, T78.2xxA is used.

CC/MCC Status — Major DRG Impact

🔢 9. ICD-10-CM Code Set (FY2026)

🔎 10. Indexing

The following alphabetic index entries are essential for shock code lookups in the FY2026 ICD-10-CM Tabular List and Alphabetic Index:

Indexing Tip: When “shock” appears in documentation without a subtype modifier, always look up “Shock” in the Alphabetic Index and follow the “see also” cross-references. The tabular instruction at R57 states: “Code also the underlying condition” — this reinforces the mandatory dual-coding approach for most shock subtypes.

🏥 11. CPT (2026)

The following CPT 2026 codes are most commonly reported in the evaluation and management of shock and its complications. Critical care codes (99291-99292) are central to shock encounters in the ICU and emergency department setting.

🧾 12. HCPCS (2026)

HCPCS Level II codes are relevant for outpatient/emergency department administration of vasopressors and other shock-related drugs. Note: for inpatient admissions under MS-DRG, drugs are included in the DRG payment and are not separately billable under HCPCS Part B. HCPCS drug codes apply primarily in outpatient, observation, and Part B settings, or for DME/home infusion.

📚 13. AHA Coding Clinic (Recent Guidance)

The following AHA Coding Clinic advisories provide authoritative guidance on shock coding. CDI and coding departments should maintain access to current Coding Clinic and review these entries prior to finalizing shock-related claims.

💰 14. HCC / Risk Adjustment (v28)

Under CMS-HCC Model v28 (implemented CY2024, fully phased in CY2026), shock codes map to HCC categories with significant risk adjustment factor (RAF) impacts. Accurate shock documentation is critical for Medicare Advantage plan risk scoring.

HCC Capture Best Practices for Shock

• Annual recapture: Sepsis/septic shock (HCC 2) requires documented evidence of active monitoring, evaluation, or treatment at every qualifying encounter. A remote history of septic shock does not carry over — the condition must be active and documented annually.
• MEAT documentation: For HCC persistence, ensure: Monitoring (vitals, cultures, labs), Evaluation (assessment statements), Assessment (condition listed in A&P), Treatment (antibiotics, vasopressors, fluids) — all documented by the provider.
• Avoid vague statements: “History of sepsis” without clarity on whether current illness constitutes a new episode may not support current-year HCC capture.
• AMI-cardiogenic shock DRG optimization: I21.x + R57.0 triggers DRG 219 (w/ MCC) — the highest-weighted AMI DRG. Ensure AMI type (STEMI: I21.0x–I21.3x; NSTEMI: I21.4), location, and cardiogenic shock documentation are explicit.

✍️ 15. CDI Query Templates

All queries below are AHIMA/ACDIS compliant — non-leading, multiple-choice format. Queries should be submitted when clinical indicators support a diagnosis not explicitly documented, when documentation is ambiguous, or when specificity is insufficient for accurate code assignment. Per ACDIS/AHIMA 2019 Query Practice Brief.

🧑‍⚕️ 16. Treatments (Clinical)

Clinical treatment of shock is time-critical. Documentation of the specific interventions performed — and the indication for each — directly supports both clinical coding accuracy and DRG/HCC optimization. CDI specialists should ensure that the medical record reflects the full scope of resuscitative and definitive treatments provided.

Universal Shock Resuscitation (All Subtypes)

• Airway management: Endotracheal intubation (31500) and mechanical ventilation (94002–94004) when hemodynamic compromise leads to respiratory failure; adds MCC (J96.00) to the encounter
• IV access: Large-bore peripheral IVs, central venous catheter (36556–36558) for vasopressor delivery and CVP monitoring
• Continuous monitoring: Arterial line (36620) for beat-to-beat BP monitoring; pulse oximetry; cardiac telemetry
• Volume resuscitation: Crystalloid (30 mL/kg for septic shock per Surviving Sepsis Campaign 2021); balanced crystalloids preferred (SMART, SALT-ED trials); blood products for hemorrhagic shock (massive transfusion protocol when indicated)

Septic Shock Management

• Sepsis bundle completion within 1–3 hours: blood cultures × 2 (before antibiotics), broad-spectrum antibiotics, lactate measurement, 30 mL/kg crystalloid bolus, vasopressors (norepinephrine first-line)
• Source control: abscess drainage, infected catheter removal, surgical debridement — document as additional procedure codes
• Vasopressin (0.03 units/min) added for norepinephrine-sparing (Surviving Sepsis Campaign recommendation)
• Corticosteroids (hydrocortisone 200 mg/24h IV) for vasopressor-refractory shock per SSC 2021

Cardiogenic Shock Management

• Emergent revascularization (PCI/CABG) for AMI-related cardiogenic shock — CPT 92941 (PCI in setting of AMI), 33533–33536 (CABG)
• Mechanical circulatory support: IABP (33967), Impella (33990–33993), VA-ECMO (33960–33966) per AHA/ACC 2022 Cardiogenic Shock Scientific Statement
• Inotropes: dobutamine (J1250), milrinone; avoid if hypotensive without support
• Diuresis: furosemide (J1940) for volume overload after initial stabilization
• Heart transplant evaluation in refractory cardiogenic shock refractory to all medical and mechanical support

Anaphylactic Shock Management

• Epinephrine (J0171) IM (thigh) immediately — first-line, non-deferrable; 0.3–0.5 mg IM auto-injector or 1:10,000 IV for refractory anaphylaxis
• Remove/stop causative agent (stop infusion, remove stinger, etc.)
• Positioning: supine with legs elevated (unless airway compromise); Trendelenburg
• Adjunctive: diphenhydramine (H1 blocker), ranitidine/famotidine (H2 blocker), methylprednisolone (J2920) — do not delay epinephrine for adjunctive therapy
• Bronchodilators (ipratropium J7644 / albuterol J7613) for bronchospasm component

MS-DRG Impact Summary

🎓 17. Patient Education / Summary

What is Shock? (Plain Language)

Shock is a medical emergency in which the body’s vital organs — heart, brain, kidneys — are not receiving enough blood and oxygen to function properly. Unlike the everyday meaning of being “shocked” by surprise, medical shock is a physical collapse of blood circulation. There are different types depending on the cause: an infection can trigger septic shock, a heart attack can cause cardiogenic shock, severe bleeding causes hypovolemic shock, a massive blood clot in the lungs can cause obstructive shock, and a severe allergic reaction causes anaphylactic shock. All types require immediate emergency treatment.

Why Documentation Matters (CDI Relevance)

From a clinical documentation and coding perspective, the type of shock documented determines:

• DRG assignment and reimbursement: All shock codes are MCC — missing shock documentation can reduce DRG payment by thousands of dollars per admission
• HCC risk adjustment: Septic shock (HCC 2, ~0.355 RAF) drives significant Medicare Advantage capitation adjustments — accurate annual documentation ensures appropriate funding for patient care
• Quality metrics: Sepsis core measures (SEP-1 bundle compliance) are tracked by CMS; complete shock documentation supports accurate quality measure reporting
• Audit defensibility: Clear provider documentation of shock type, vasopressor requirement, lactate levels, and organ dysfunction protects against OIG/RAC audit findings

Key Documentation Reminders for Clinicians

• Always specify the type of shock — do not document “shock” alone; specify septic, cardiogenic, hypovolemic, anaphylactic, or obstructive
• For septic shock: document (1) the infection source and organism, (2) vasopressor requirement, (3) lactate level and response to resuscitation — this directly corresponds to the Sepsis-3 definition and supports R65.21
• For cardiogenic shock complicating AMI: explicitly link the shock to the acute MI in your documentation; specify AMI type (STEMI vs. NSTEMI) and location
• For anaphylactic shock: document the causative agent when identified — this enables specific T-code assignment and is required for complete coding
• Avoid vague language: “hemodynamically unstable,” “pressors required,” “circulatory compromise” — while these support clinical picture, the explicit diagnosis of “[type] shock” provides the legal basis for code assignment
• Document all evidence of end-organ hypoperfusion: lactate values, urine output (mL/hr), creatinine trend, mental status changes, hepatic enzymes — these support both clinical validity and organ dysfunction code assignment

Common Patient/Family Questions (CDI Context)

• “Why did the doctor say ‘septic shock’ vs. just ‘sepsis’?” — Septic shock is the most severe form of sepsis; it means the infection has caused blood pressure to drop so severely that vasopressor medications (drugs to keep blood pressure up) are required, AND the blood lactate level (a marker of cellular oxygen shortage) remains elevated despite IV fluids. Both criteria must be met.
• “Is ‘heart failure’ the same as ‘cardiogenic shock’?” — No. Heart failure means the heart is not pumping efficiently; cardiogenic shock means the pumping failure is so severe that vital organs are not receiving adequate blood flow and intervention is immediately life-threatening without mechanical or pharmacological support.
• “Can shock be caused by an allergy?” — Yes. Anaphylactic shock is a severe, whole-body allergic reaction that causes blood vessels to dilate massively and blood pressure to drop catastrophically. Epinephrine (adrenaline) is the only first-line treatment — antihistamines alone are insufficient for anaphylactic shock.

Quality Measure Intersections

• SEP-1 (Severe Sepsis and Septic Shock Bundle): CMS Hospital Inpatient Quality Reporting Program measure; tracks blood culture timing, antibiotic timing, fluid resuscitation, and vasopressor initiation in septic shock. Coding accuracy for R65.21 directly affects SEP-1 denominator capture.
• PC-02 (Elective Delivery): Not directly applicable, but O75.1 (obstetric shock) encounter data feeds into maternal quality reporting.
• OP-27 / Hospital-Acquired Condition (HAC) Reduction: Certain postprocedural shock scenarios (T81.12xA — postprocedural septic shock) may trigger HAC review if hospital-onset sepsis is flagged. CDI should ensure accurate distinction between community-acquired and hospital-onset infection in surgical patients.

About this Guide

This Clinical Documentation Guide is published by CCO Academy and is intended for credentialed coding, CDI, and clinical documentation professionals. Content is updated for FY2026 ICD-10-CM (effective October 1, 2025). All code assignments should be verified against the official ICD-10-CM Tabular List, AHA Coding Clinic, and applicable payer-specific policies. This guide does not constitute legal, medical, or compliance advice.

Last reviewed: April 2026 · Next scheduled review: October 2026 (FY2027 update)